首页> 中文期刊> 《浙江中西医结合杂志》 >PPARγC161T基因多态性表达与进展性脑梗死相关性研究

PPARγC161T基因多态性表达与进展性脑梗死相关性研究

         

摘要

Objective To investigate the relationship between C161T polymorphism on peroxisome proliferator-activated receptor gamma(PPARγ) gene and progressive ischemic stroke. Methods The C161T variants on PPARγgene of 225 patients with progressive ischemic stroke and 225 non-progressive ischemic stroke patients matched with age, gender, and past history of disease was examined by using polymerase chain reaction restriction fragment length polymorphism (PCR-RFLP). The serum PPARγ was measured by ELISA. Results No statistical differences in frequencies of genotype and allele was noted between the progressive and non-progressive ischemic stroke pa-tients (P>0.05). At admission, 72h after admission and 4 weeks after onset, the C allele carriers had lower levels of PPARγ, compared with the T allele carriers (P<0.01). In C allele carriers, the PPARγ expression in progressive ischemic stroke patients was significantly lower than that in non-progressive patients(P<0.01). Compared with base-line, the PPARγ expression significantly increased in each genotype at 72h after admission and 4 weeks after onset (P<0.01). Conclusion The C161T polymorphism on PPARγ gene may be related to onset of progressive ischemic stroke.%目的:探讨PPARγC161T基因多态性及其表达与进展性脑梗死的关系。方法进展性脑梗死患者225例纳入进展组,同期住院的非进展性脑梗死患者225例为非进展组。应用多聚酶链-限制性片段长度多态性(PCR-RFLP)技术检测两组PPARγ基因C161T的基因型,酶联免疫吸附(ELISA)法检测PPARγ基因表达水平。结果进展组和非进展组患者PPARγ C161T基因多态性频率无明显差异(P>0.05)。入院时、入院后72h以及发病后4周,携带C等位基因脑梗死患者的PPARγ表达量均低于携带T基因的脑梗死患者(P<0.01),并且在携带C等位基因患者中进展组PPARγ表达量低于非进展组(P<0.01)。与入院时比较,入院后72h以及发病后4周各基因型的PPARγ表达量明显升高(P<0.01)。结论 PPARγC161T基因多态性的表达可能与进展性脑梗死的发生有关。

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号